Equity Details
Price & Market Data
Price: $7.14
Daily Change: -$0.11 / 1.54%
Daily Range: $6.97 - $7.44
Market Cap: $259,136,592
Daily Volume: 63,305
Performance Metrics
1 Week: -1.79%
1 Month: 13.88%
3 Months: 12.26%
6 Months: 19.40%
1 Year: 66.82%
YTD: -9.28%
About Profound Medical Corp. (PROF)
Find all you need to know about Profound Medical Corp. (PROF)'s market performance. The stock is valued at 7.14, showing a daily change of -$0.11 / 1.54%. Its market capitalization is 259,136,592. Dive into its short-term and long-term performance trends.
Company Details
Employees: 162
Sector: Health technology
Industry: Medical specialties
Country: Canada
Details
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.